Forbes this week released its annual "30 Under 30 in Healthcare" list, which includes biological researchers, entrepreneurs, physicians, and PhD students under 30 years of age who are "tackling health care issues at every scale."

Doctors at Duke University Hospital have performed the country's first-ever adult heart transplant through a process called donation after circulatory death, and one of the surgeons involved says the process could expand the heart transplant donor pool by as much as 30%.

South Bend, Indiana, Mayor Pete Buttigieg (D), who is seeking the 2020 Democratic nomination for president, on Tuesday released a plan intended to combat inequality in the U.S. health care system.

Spurred by the growing popularity of plant-based meat substitutes, stakeholders in the meat industry have released a series of ads decrying what they call "ultra-processed imitations"—and health experts are cautioning against any quick endorsements of the new products.

Exercise might be linked to a reduced risk of depression, even in people who are genetically predisposed to the condition, according to recent research that analyzed data from the ongoing Partners Biobank study.

Early research supports the theory that humans age as a result of primeval genetic mechanisms intended to regulate and repair our aging cells, but there might be ways to "turn off" these mechanisms to slow or even reverse aging, according to David Sinclair, a professor of genetics at Harvard Medical School, and Matthew LaPlante, an associate professor of journalism at Utah State University.

The latest fad in Silicon Valley is so-called "dopamine fasting," in which an individual abstains from smartphones, computers, and even eye contact in order to supposedly curb "addiction" to technology—but experts are skeptical of whether the practice really works.

Two days before Google was set to publicly share over 100,000 images of chest X-rays obtained under a partnership with NIH, the federal health agency called Google and informed company researchers that some of the images included personal health data—leading Google to promptly cancel the project.

Researchers at Geisinger recently announced that they have developed an algorithm that uses electrocardiogram data to determine whether a person will die within a year—but they are not sure how the algorithm works.

Johnson & Johnson's Jansen pharmaceutical subsidiary will launch the company's first-ever solely digital trial to test a potential new use for its diabetes drug Invokana, the company announced last weekend at the American Heart Association conference.